Allogene Therapeutics
Clinical trials sponsored by Allogene Therapeutics, explained in plain language.
-
New 'Ready-Made' cell therapy tested for tough blood cancers
Disease control OngoingThis study is testing a new type of cell therapy called ALLO-501A for adults with large B-cell lymphoma or CLL/SLL that has come back or hasn't responded to other treatments. The goal is to see if this 'off-the-shelf' therapy, made from donor cells instead of the patient's own, i…
Phase: PHASE1, PHASE2 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Experimental cell treatment offers hope for tough kidney cancers
Disease control OngoingThis early-stage trial is testing a new cell therapy called ALLO-316 for people with advanced kidney cancer that has spread. Researchers want to find the safest and most effective dose by giving patients different amounts of the treatment after they receive chemotherapy. The stud…
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC